What You Should Know:
- Glooko, a provider of remote patient monitoring and digital health solutions for diabetes and other chronic conditions, today announced it has acquired xbird, a German-based health AI company developing JITAI ( Just In Time Adaptive Intervention) technologies to support patients and their providers in predicting behavior and managing diabetes.
- The addition of xbird expands Glooko’s advanced analytics capabilities and tools, further broadening Glooko’s platform
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
Honeywell Makes Strategic Investment in RapidSOS’s ER Data Platform
What You Should Know:
- Today, Honeywell announced it has made a strategic investment in RapidSOS, an NYC-based emergency response data platform, to further modernize and digitize the public safety communications process.
- In addition to the strategic investment, Honeywell Connected Life Safety System (CLSS) will integrate with the RapidSOS emergency response data platform to provide faster, more accurate communications
Read More
Implementing Responsible AI to Drive Innovation in Clinical Research & Precision Medicine
Researchers might be skeptical and, with people’s lives at stake, that’s understandable. Here’s how to take advantage of the advances while ensuring safeguards are in place.
As artificial intelligence (AI) and machine learning drive innovation and disruption in clinical trials and precision medicine, questions around the responsible use of AI have moved to the forefront of debates among healthcare stakeholders – patients, providers, regulatory authorities, payors and sponsors. To what extent,
Read More
Enhancing Workflow Automation for Healthcare Professionals
Like employers in most industries, healthcare organizations are battling to fill open positions amid the current tight labor market. And new reports show a growing wave of nursing shortages. This widespread scarcity of healthcare workers is forcing providers to cope by having practitioners handle tasks like data entry along with their normal patient care duties. That loss of time means organizations miss out on opportunities to generate more revenue with their top talent.
Fortunately,
Read More
7 Burning Questions from Life Sciences Companies on Using AI Agents
Each day life science companies respond to numerous medical information inquires – many of which are similar in nature or can be simply addressed. However, as we have seen in the news reports with the Great Resignation and many workers searching for new careers, the number of individuals interested in working in a medical information contact center may be waning. When you combine this with the rising volume of inquiries or medical inquiries and patient expectations for a real-time response to
Read More
Sema4 Acquires GeneDx for $623M to Strengthen AI-Driven Genomic Platform
What You Should Know:
- Today, Sema4 (Nasdaq: SMFR), a health intelligence company, announced it has signed a definitive agreement to acquire GeneDx, a leader in genomic testing and analysis, at a purchase price representing approximately $623 million, strengthening its market-leading health intelligence and genomic screening offerings.
- The combined company is projected to deliver $350 million in pro forma 2022 revenue. In connection with the acquisition,
Read More
We Recall Drugs with Adverse Effects, So Why Not Recall AI Algorithms with Racial Bias?
Over the last decade, AI has transformed from a futuristic, hype-driven tool, to now being a daily part of our lives. We use AI for everything from unlocking our smartphones, to evaluating our credit scores, to helping clinicians make patient care decisions. In particular, the potential of AI to transform drug development and patient care is unparalleled – its ability to gather objective insights can help elevate a clinical trial’s data and bring potentially life-saving drugs to people in need
Read More
Protai Nabs $8M for AI-Powered Drug Discovery Platform
What You Should Know:
- Protai, a Tel Aviv, Israel-based AI-powered drug discovery startup, today announced its emergence from stealth, along with an $8 million seed financing round co-led by Grove Ventures and Pitango HealthTech.
- Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat complex diseases.
Proteomics-based Platform for Faster and More Accurate Drug Discovery
Despite the significant
Read More
Using Real-World Evidence (RWE) & AI to Enable Better Clinical Care
During the prescribing process, a physician’s ability to accurately and reliably match the most appropriate therapy option with the patient at hand is limited by the amount and quality of clinical information that is available. While randomized clinical trials are considered the gold standard for establishing the safety and efficacy of prescription medications, and the clinical findings verified from the trial inform the label on the approved therapy, the overall utility of such trials is
Read More
Using Machine Learning in the Evolving Landscape of Real-World Data
According to the Food and Drug Administration (FDA), the term real-world data (RWD) refers to routinely collected data relating to patient health status and the delivery of healthcare services, and real-world evidence (RWE) is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from the analysis of RWD. Both RWD and RWE have increasingly attracted attention in the healthcare industry for years now, and rightly so, considering that the healthcare
Read More
